Manage Transitions of Care from Admissions to Post-Discharge with the Next-Generation of Olio

2 weeks ago

Olio, a leading healthcare software company, announces continued investment for Skilled Nursing Operators to support transitions of care by reducing…

Helix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine Development

2 weeks ago

SAN MATEO, Calif., Jan. 7, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics company, today announced a multi-year strategic collaboration…

Teal Health Expands Nationwide, Bringing the Only FDA-Authorized Device for At-Home Cervical Cancer Screening to All 50 States

2 weeks ago

For the first time ever, women across the U.S. have access to a comfortable, convenient, and accurate at-home cervical cancer…

Somite Becomes Cellular Intelligence, as It Builds the First Universal Virtual Cell-Signaling Model

2 weeks ago

New white paper details key technical milestones and validation of the company's proprietary, capsule-based platform to accelerate breakthroughs across human…

Teal Health Expands Nationwide, Bringing the Only FDA-Authorized Device for At-Home Cervical Cancer Screening to All 50 States

2 weeks ago

For the first time ever, women across the U.S. have access to a comfortable, convenient, and accurate at-home cervical cancer…

Knipper Health Rebrands as CareTria to Deliver a Faster Path from Order to Therapy

2 weeks ago

The new brand reflects an integrated platform built to accelerate therapy initiation, increase patient conversions, and optimize gross-to-net performance.SOMERSET, N.J.,…

Knipper Health Rebrands as CareTria to Deliver a Faster Path from Order to Therapy

2 weeks ago

The new brand reflects an integrated platform built to accelerate therapy initiation, increase patient conversions, and optimize gross-to-net performance.SOMERSET, N.J.,…

Teal Health Expands Nationwide, Bringing the Only FDA-Authorized Device for At-Home Cervical Cancer Screening to All 50 States

2 weeks ago

For the first time ever, women across the U.S. have access to a comfortable, convenient, and accurate at-home cervical cancer…

InterVenn Biosciences Partners with Aranscia to Accelerate Commercialization of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test

2 weeks ago

Aranscia's Suite of Laboratory and Technology Solutions to Support InterVenn's Commercialization ProgramSOUTH SAN FRANCISCO, Calif. and HOUSTON, Jan. 7, 2026…

InterVenn Biosciences Partners with Aranscia to Accelerate Commercialization of GlycoKnow™ Non-Invasive Ovarian Cancer Diagnostic Test

2 weeks ago

Aranscia's Suite of Laboratory and Technology Solutions to Support InterVenn's Commercialization ProgramSOUTH SAN FRANCISCO, Calif. and HOUSTON, Jan. 7, 2026…